Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-03-005641
Filing Date
2003-09-16
Accepted
2003-09-16 15:41:33
Documents
1
Period of Report
2003-09-03

Document Format Files

Seq Description Document Type Size
1 kerkman_ex.html 4  
1 kerkman_ex.xml 4 3418
  Complete submission text file 0001144204-03-005641.txt   5354
Mailing Address 420 LEXINGTON AVENUE SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 300 NEW YORK NY 10170 212-297-6221
HEMOXYMED INC (Issuer) CIK: 0000872947 (see all company filings)

EIN.: 391661164 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 21 CREMIN DRIVE LAKE VILLA IL 60046
Business Address 21 CREMIN DRIVE LAKE VILLA IL 60046 8473568217
KERKMAN DANIEL J (Reporting) CIK: 0001263235 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13835 | Film No.: 03897652